Les Funtleyder is a healthcare portfolio manager at E Squared Capital Management and currently serves as the Chief Financial Officer for Applied Therapeutics. He was formerly the director of strategic investments for Opko Health and held roles as strategist and portfolio manager for Miller Tabak Health Transformation Fund, Provident Advisors, and UBS Warburg.
Mr. Funtleyder, the author of Healthcare Investing: Profiting from the New World of Pharma, Biotech, and Health Care Services (McGraw-Hill Finance & Investing, 2009), is widely quoted in The Wall Street Journal, The New York Times, and the Financial Times and makes frequent appearances on CNBC, Bloomberg, and National Public Radio. He is an adjunct professor of public health at Columbia University.
Mr. Funtleyder sits on the boards of HealthEngine, Reviva Pharmaceuticals, Regain Lasers, Aceso Global, an advisory firm for health systems in low and middle income countries, and Zentynel, a South American life sciences venture fund.
Mr. Funtleyder earned his master’s in public health from the Mailman School of Public Health at Columbia University.